Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-175437
Filing Date
2025-08-07
Accepted
2025-08-07 16:14:29
Documents
69
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q scph-20250630.htm   iXBRL 10-Q 2098764
2 EX-31.1 scph-ex31_1.htm EX-31.1 15726
3 EX-31.2 scph-ex31_2.htm EX-31.2 15100
4 EX-32.1 scph-ex32_1.htm EX-32.1 12873
5 EX-32.2 scph-ex32_2.htm EX-32.2 12115
  Complete submission text file 0001193125-25-175437.txt   9166098

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT scph-20250630.xsd EX-101.SCH 1206070
72 EXTRACTED XBRL INSTANCE DOCUMENT scph-20250630_htm.xml XML 1784873
Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38293 | Film No.: 251194194
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)